HMB-001 clinical trials

A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia

This study is testing a new medicine called HMB-001 for a rare bleeding disorder called Glanzmann Thrombasthenia. It aims to see if HMB-001 is safe, well-tolerated, and can help reduce bleeding.